NMNAT2 anticorps
Aperçu rapide pour NMNAT2 anticorps (ABIN1169224)
Antigène
Voir toutes NMNAT2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Recognizes human NMNAT2.
-
Réactivité croisée
- Humain
-
Stérilité
- 0.2 μm filtered
-
Immunogène
- Recombinant human NMNAT2.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 1 year after receipt when stored at -20°C. -
Date de péremption
- 12 months
-
-
- NMNAT2 (Nicotinamide Nucleotide Adenylyltransferase 2 (NMNAT2))
-
Autre désignation
- NMNAT2
-
Sujet
- NMNAT2 catalyzes the formation of NAD+ from nicotinamide mononucleotide (NMN) and ATP. Can also use the deamidated form nicotinic acid mononucleotide (NaMN) as a substrate but with lower efficiency. Also catalyzes the reverse reaction, i.e. the pyrophosphorolytic cleavage of NAD+. Highly expressed in brain, in particular in cerebrum, cerebellum, occipital lobe, frontal lobe, temporal lobe and putamen. Also found in the heart, skeletal muscle, pancreas and islets of Langerhans. Has been shown to correlate with Alzheimer's disease in APPswe/PS1dE9 transgenic mice and delayed wallerian degeneration in cultured superior cervical ganglia (SCGs) from morphological changes, microtubule destruction and neurofilament degradation.
-
UniProt
- Q9BZQ4
Antigène
-